These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10302795)

  • 21. The medical directorship of renal dialysis facilities under the new Medicare conditions for coverage: challenges and opportunities.
    DeOreo PB
    Blood Purif; 2009; 27(1):16-21. PubMed ID: 19169012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicare program; home health agencies: conditions of participation and reduction in recordkeeping requirements--HCFA. Interim final rule with comment period.
    Fed Regist; 1989 Aug; 54(155):33354-73. PubMed ID: 10303704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medicare and Medicaid programs; physicians' referrals to health care entities with which they have financial relationships. Health Care Financing Administration (HCFA), HHS. Final rule with comment period.
    Fed Regist; 2001 Jan; 66(3):856-965. PubMed ID: 11503745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicare and Medicaid programs; religious nonmedical health care institutions and advance directives. Final rule.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2003 Nov; 68(229):66710-21. PubMed ID: 14649654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicare program; changes to the hospital inpatient prospective payment system for acute care hospitals and fiscal year 2010 rates; and changes to the long-term care hospital prospective payment system and rate years 2010 and 2009 rates. Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2009 Aug; 74(165):43753-4236. PubMed ID: 19827228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medicare program; protocol for the reuse of dialysis bloodlines--HCFA. Proposed rule.
    Fed Regist; 1988 Jul; 53(144):28236-39. PubMed ID: 10302616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicare program; standards for reuse of hemodialyzer filters and other dialysis supplies--HCFA. Final rule.
    Fed Regist; 1987 Oct; 52(191):36926-35. PubMed ID: 10301900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicare program; electronic submission of cost reports: revision to effective date of cost reporting period. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 May; 70(102):30640-3. PubMed ID: 15920827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conditions for coverage of suppliers of ESRD services self-dialysis and home dialysis training--Health Care Financing Administration. Notice of proposed rulemaking.
    Fed Regist; 1981 Jan; 46(10):3794-800. PubMed ID: 10298077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicare program; appeals procedures for determinations that affect participation in Medicare--HCFA. Final rule with comment period.
    Fed Regist; 1987 Jun; 52(113):22444-54. PubMed ID: 10301575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicare program: changes to the Medicare claims appeal procedures. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Mar; 70(44):11419-99. PubMed ID: 15754467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicare and Medicaid programs; religious nonmedical health care institutions and advance directives. Health Care Financing Administration (HCFA), HHS. Interim final rule with comment period.
    Fed Regist; 1999 Nov; 64(229):67028-52. PubMed ID: 11010664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescription drugs in Medicare and the ESRD program.
    Powe NR
    Semin Nephrol; 2000 Nov; 20(6):535-42. PubMed ID: 11111855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicare program; changes to the hospital inpatient prospective payment systems and rates and costs of graduate medical education: fiscal year 2002 rates; provisions of the Balanced Budget Refinement Act of 1999; and provisions of the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000. Final rules.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2001 Aug; 66(148):39827-40102. PubMed ID: 11732554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicare program: review of national coverage determinations and local coverage determinations. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Nov; 68(216):63691-731. PubMed ID: 14610762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicare program; coverage of ambulance services and vehicle and staff requirements. Health Care Financing Administration (HCFA), HHS. Final rule with comment period.
    Fed Regist; 1999 Jan; 64(15):3637-50. PubMed ID: 11010681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The legislative and regulatory process in the end-stage renal disease (ESRD) program, 1973 through 1997.
    Hull AR
    Semin Nephrol; 1997 May; 17(3):160-9. PubMed ID: 9165645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicare program; payment for home intravenous drug therapy services--HCFA. Proposed rule.
    Fed Regist; 1989 Nov; 54(215):46938-53. PubMed ID: 10303985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.